Genomic medicine in clinical practice:national genomic medicine program in Japan
作者机构:Department of Genetic Medicine and ServicesNational Cancer Center HospitalTokyo 104-0045Japan Department of Diagnostic PathologyNational Cancer Center HospitalTokyo 104-0045Japan Clinical Research Support OffceClinical Research Coordinating SectionBiobank Translational Research Support SectionNational Cancer Center HospitalTokyo 104-0045Japan Department of Pathology and Clinical LaboratoriesNational Cancer Center Hospital EastChiba 277-8577Japan Division of Molecular PharmacologyNational Cancer Center Research InstituteTokyo 104-0045Japan National Cancer Center Research InstituteTokyo 104-0045Japan Department of Laboratory MedicineNational Cancer Center HospitalTokyo 104-0045Japan Department of Experimental TherapeuticsNational Cancer Center HospitalTokyo 104-0045Japan Division of Genome BiologyNational Cancer Center Research InstituteTokyo 104-0045Japan
出 版 物:《Cancer Biology & Medicine》 (癌症生物学与医学(英文版))
年 卷 期:2024年第21卷第1期
页 面:4-9页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
摘 要:Cancer statistics in Japan Cancer is the most common cause of death in Japan based on Statistics 2021~*** statistics were first gathered,infectious diseases,such as tuberculosis,and cerebrovascular disease have been the main causes of death in *** surpassed cerebrovascular disease as the main cause of death in 1981,and the number of cancer deaths has *** 38,000 people died of cancer in *** National Cancer Center(NCC)reported that the 5-year survival rate for patients with cancer was improving(62%for males and 66.9%for females)in a population-based cancer registry.